nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—panic disorder—Bupropion—obesity	0.165	0.561	CpDpCtD
Citalopram—bipolar disorder—Topiramate—obesity	0.129	0.439	CpDpCtD
Citalopram—HTR2C—obesity	0.0687	0.381	CbGaD
Citalopram—SLC6A4—obesity	0.0569	0.316	CbGaD
Citalopram—CYP2E1—obesity	0.0545	0.303	CbGaD
Citalopram—SLC6A3—Diethylpropion—obesity	0.0257	0.0707	CbGbCtD
Citalopram—SLC6A3—Phendimetrazine—obesity	0.0195	0.0536	CbGbCtD
Citalopram—SLC6A3—Sibutramine—obesity	0.0195	0.0536	CbGbCtD
Citalopram—SLC6A2—Diethylpropion—obesity	0.0188	0.0517	CbGbCtD
Citalopram—SLC6A4—Sibutramine—obesity	0.0171	0.0469	CbGbCtD
Citalopram—SLC6A3—Benzphetamine—obesity	0.0148	0.0406	CbGbCtD
Citalopram—SLC6A3—Phentermine—obesity	0.0148	0.0406	CbGbCtD
Citalopram—SLC6A2—Phendimetrazine—obesity	0.0143	0.0392	CbGbCtD
Citalopram—SLC6A2—Sibutramine—obesity	0.0143	0.0392	CbGbCtD
Citalopram—SLC6A3—Phenylpropanolamine—obesity	0.0141	0.0387	CbGbCtD
Citalopram—SLC6A4—Phentermine—obesity	0.0129	0.0355	CbGbCtD
Citalopram—SLC6A3—Bupropion—obesity	0.0126	0.0345	CbGbCtD
Citalopram—ADRA1A—Phendimetrazine—obesity	0.0123	0.0339	CbGbCtD
Citalopram—SLC6A3—Methamphetamine—obesity	0.0118	0.0325	CbGbCtD
Citalopram—SLC6A2—Phentermine—obesity	0.0108	0.0297	CbGbCtD
Citalopram—SLC6A2—Benzphetamine—obesity	0.0108	0.0297	CbGbCtD
Citalopram—SLC6A4—Methamphetamine—obesity	0.0103	0.0284	CbGbCtD
Citalopram—SLC6A2—Phenylpropanolamine—obesity	0.0103	0.0283	CbGbCtD
Citalopram—ADRA1A—Benzphetamine—obesity	0.00935	0.0257	CbGbCtD
Citalopram—SLC6A2—Bupropion—obesity	0.0092	0.0253	CbGbCtD
Citalopram—ADRA1A—Phenylpropanolamine—obesity	0.00892	0.0245	CbGbCtD
Citalopram—SLC6A2—Methamphetamine—obesity	0.00865	0.0238	CbGbCtD
Citalopram—CYP2B6—Benzphetamine—obesity	0.00671	0.0184	CbGbCtD
Citalopram—CYP2E1—Bupropion—obesity	0.00579	0.0159	CbGbCtD
Citalopram—CYP2B6—Bupropion—obesity	0.00571	0.0157	CbGbCtD
Citalopram—CYP2E1—Cimetidine—obesity	0.00425	0.0117	CbGbCtD
Citalopram—CYP1A2—Phentermine—obesity	0.00394	0.0108	CbGbCtD
Citalopram—CYP1A2—Phenylpropanolamine—obesity	0.00376	0.0103	CbGbCtD
Citalopram—CYP1A2—Bupropion—obesity	0.00335	0.00919	CbGbCtD
Citalopram—CYP2D6—Phentermine—obesity	0.00324	0.00891	CbGbCtD
Citalopram—CYP2D6—Bupropion—obesity	0.00276	0.00757	CbGbCtD
Citalopram—CYP3A4—Sibutramine—obesity	0.00272	0.00747	CbGbCtD
Citalopram—CYP2C19—Cimetidine—obesity	0.00266	0.00731	CbGbCtD
Citalopram—CYP2D6—Methamphetamine—obesity	0.00259	0.00712	CbGbCtD
Citalopram—CYP1A2—Cimetidine—obesity	0.00246	0.00675	CbGbCtD
Citalopram—ABCB1—Cimetidine—obesity	0.00215	0.0059	CbGbCtD
Citalopram—CYP3A4—Benzphetamine—obesity	0.00206	0.00566	CbGbCtD
Citalopram—CYP2D6—Cimetidine—obesity	0.00202	0.00556	CbGbCtD
Citalopram—CYP3A4—Bupropion—obesity	0.00175	0.00482	CbGbCtD
Citalopram—CYP2C19—Topiramate—obesity	0.00174	0.00479	CbGbCtD
Citalopram—SLC6A2—sympathetic nervous system—obesity	0.00144	0.134	CbGeAlD
Citalopram—CYP3A4—Orlistat—obesity	0.00143	0.00393	CbGbCtD
Citalopram—CYP3A4—Cimetidine—obesity	0.00129	0.00353	CbGbCtD
Citalopram—SLC6A2—autonomic nervous system—obesity	0.000966	0.0901	CbGeAlD
Citalopram—CYP3A4—Topiramate—obesity	0.000843	0.00231	CbGbCtD
Citalopram—Escitalopram—HTR2C—obesity	0.000751	0.547	CrCbGaD
Citalopram—Escitalopram—SLC6A4—obesity	0.000622	0.453	CrCbGaD
Citalopram—SLC6A3—hindbrain—obesity	0.000505	0.047	CbGeAlD
Citalopram—SLC6A4—hindbrain—obesity	0.000462	0.0431	CbGeAlD
Citalopram—ADRA1A—hindbrain—obesity	0.000378	0.0353	CbGeAlD
Citalopram—SLC6A3—respiratory system—obesity	0.000308	0.0287	CbGeAlD
Citalopram—SLC6A4—respiratory system—obesity	0.000282	0.0263	CbGeAlD
Citalopram—SLC6A2—respiratory system—obesity	0.000249	0.0232	CbGeAlD
Citalopram—CYP2D6—hindbrain—obesity	0.000223	0.0208	CbGeAlD
Citalopram—CHRM1—cardiovascular system—obesity	0.000215	0.0201	CbGeAlD
Citalopram—CYP1A2—respiratory system—obesity	0.000191	0.0178	CbGeAlD
Citalopram—CYP2B6—respiratory system—obesity	0.000183	0.0171	CbGeAlD
Citalopram—SLC6A4—digestive system—obesity	0.00018	0.0167	CbGeAlD
Citalopram—HRH1—respiratory system—obesity	0.000179	0.0167	CbGeAlD
Citalopram—ADRA1A—cardiovascular system—obesity	0.000177	0.0165	CbGeAlD
Citalopram—CYP2E1—respiratory system—obesity	0.000172	0.016	CbGeAlD
Citalopram—ADRA1A—adipose tissue—obesity	0.000156	0.0146	CbGeAlD
Citalopram—CYP2B6—adrenal cortex—obesity	0.000154	0.0143	CbGeAlD
Citalopram—SLC6A2—adrenal gland—obesity	0.000151	0.014	CbGeAlD
Citalopram—CYP2C19—digestive system—obesity	0.000149	0.0139	CbGeAlD
Citalopram—SLC6A4—endocrine gland—obesity	0.000148	0.0138	CbGeAlD
Citalopram—CHRM1—endocrine gland—obesity	0.000148	0.0138	CbGeAlD
Citalopram—CYP2B6—cardiovascular system—obesity	0.00014	0.0131	CbGeAlD
Citalopram—ADRA1A—adrenal gland—obesity	0.00014	0.0131	CbGeAlD
Citalopram—CYP2E1—cardiovascular system—obesity	0.000132	0.0123	CbGeAlD
Citalopram—SLC6A2—endocrine gland—obesity	0.000131	0.0122	CbGeAlD
Citalopram—CYP2C19—endocrine gland—obesity	0.000123	0.0115	CbGeAlD
Citalopram—CYP1A2—digestive system—obesity	0.000121	0.0113	CbGeAlD
Citalopram—ADRA1A—endocrine gland—obesity	0.000121	0.0113	CbGeAlD
Citalopram—HRH1—adipose tissue—obesity	0.000121	0.0113	CbGeAlD
Citalopram—CYP2B6—digestive system—obesity	0.000116	0.0109	CbGeAlD
Citalopram—HRH1—digestive system—obesity	0.000114	0.0106	CbGeAlD
Citalopram—CYP2B6—adrenal gland—obesity	0.000111	0.0103	CbGeAlD
Citalopram—CYP2C19—liver—obesity	0.000111	0.0103	CbGeAlD
Citalopram—ADRA1A—liver—obesity	0.000109	0.0102	CbGeAlD
Citalopram—CYP2E1—digestive system—obesity	0.000109	0.0102	CbGeAlD
Citalopram—HRH1—adrenal gland—obesity	0.000108	0.0101	CbGeAlD
Citalopram—CYP2E1—adrenal gland—obesity	0.000104	0.00971	CbGeAlD
Citalopram—ABCB1—islet of Langerhans—obesity	0.000104	0.00967	CbGeAlD
Citalopram—CYP1A2—endocrine gland—obesity	0.0001	0.00936	CbGeAlD
Citalopram—ABCB1—respiratory system—obesity	9.79e-05	0.00913	CbGeAlD
Citalopram—CYP2B6—endocrine gland—obesity	9.62e-05	0.00897	CbGeAlD
Citalopram—HRH1—endocrine gland—obesity	9.4e-05	0.00876	CbGeAlD
Citalopram—CYP1A2—liver—obesity	9.05e-05	0.00844	CbGeAlD
Citalopram—CYP2E1—endocrine gland—obesity	9.03e-05	0.00842	CbGeAlD
Citalopram—CYP3A4—digestive system—obesity	8.79e-05	0.0082	CbGeAlD
Citalopram—CYP2B6—liver—obesity	8.68e-05	0.00809	CbGeAlD
Citalopram—CYP2D6—digestive system—obesity	8.65e-05	0.00807	CbGeAlD
Citalopram—ABCB1—adrenal cortex—obesity	8.22e-05	0.00766	CbGeAlD
Citalopram—CYP2E1—liver—obesity	8.14e-05	0.00759	CbGeAlD
Citalopram—ABCB1—cardiovascular system—obesity	7.5e-05	0.00699	CbGeAlD
Citalopram—CYP3A4—endocrine gland—obesity	7.27e-05	0.00678	CbGeAlD
Citalopram—CYP2D6—endocrine gland—obesity	7.15e-05	0.00667	CbGeAlD
Citalopram—ABCB1—pituitary gland—obesity	6.64e-05	0.00619	CbGeAlD
Citalopram—ABCB1—adipose tissue—obesity	6.61e-05	0.00617	CbGeAlD
Citalopram—CYP3A4—liver—obesity	6.55e-05	0.00611	CbGeAlD
Citalopram—CYP2D6—liver—obesity	6.45e-05	0.00601	CbGeAlD
Citalopram—ABCB1—digestive system—obesity	6.22e-05	0.0058	CbGeAlD
Citalopram—ABCB1—adrenal gland—obesity	5.93e-05	0.00553	CbGeAlD
Citalopram—ABCB1—endocrine gland—obesity	5.14e-05	0.0048	CbGeAlD
Citalopram—ABCB1—liver—obesity	4.64e-05	0.00432	CbGeAlD
Citalopram—Dry mouth—Sibutramine—obesity	2.26e-05	0.000219	CcSEcCtD
Citalopram—Aspartate aminotransferase increased—Topiramate—obesity	2.25e-05	0.000218	CcSEcCtD
Citalopram—Toxic epidermal necrolysis—Topiramate—obesity	2.25e-05	0.000218	CcSEcCtD
Citalopram—Nervous system disorder—Orlistat—obesity	2.24e-05	0.000217	CcSEcCtD
Citalopram—Nasopharyngitis—Topiramate—obesity	2.24e-05	0.000217	CcSEcCtD
Citalopram—Confusional state—Sibutramine—obesity	2.23e-05	0.000216	CcSEcCtD
Citalopram—Vision blurred—Bupropion—obesity	2.23e-05	0.000216	CcSEcCtD
Citalopram—Skin disorder—Orlistat—obesity	2.22e-05	0.000215	CcSEcCtD
Citalopram—Tremor—Bupropion—obesity	2.22e-05	0.000215	CcSEcCtD
Citalopram—Gastritis—Topiramate—obesity	2.22e-05	0.000215	CcSEcCtD
Citalopram—Oedema—Sibutramine—obesity	2.22e-05	0.000215	CcSEcCtD
Citalopram—Anaphylactic shock—Sibutramine—obesity	2.22e-05	0.000215	CcSEcCtD
Citalopram—Hyperhidrosis—Orlistat—obesity	2.21e-05	0.000214	CcSEcCtD
Citalopram—Alanine aminotransferase increased—Topiramate—obesity	2.21e-05	0.000214	CcSEcCtD
Citalopram—Muscular weakness—Topiramate—obesity	2.21e-05	0.000214	CcSEcCtD
Citalopram—Infection—Sibutramine—obesity	2.2e-05	0.000213	CcSEcCtD
Citalopram—Ill-defined disorder—Bupropion—obesity	2.2e-05	0.000213	CcSEcCtD
Citalopram—Anaemia—Bupropion—obesity	2.19e-05	0.000212	CcSEcCtD
Citalopram—Shock—Sibutramine—obesity	2.18e-05	0.000211	CcSEcCtD
Citalopram—Abdominal distension—Topiramate—obesity	2.18e-05	0.000211	CcSEcCtD
Citalopram—Agitation—Bupropion—obesity	2.17e-05	0.000211	CcSEcCtD
Citalopram—Thrombocytopenia—Sibutramine—obesity	2.17e-05	0.00021	CcSEcCtD
Citalopram—Dysphagia—Topiramate—obesity	2.16e-05	0.00021	CcSEcCtD
Citalopram—Asthma—Topiramate—obesity	2.16e-05	0.00021	CcSEcCtD
Citalopram—Angioedema—Bupropion—obesity	2.16e-05	0.000209	CcSEcCtD
Citalopram—Tachycardia—Sibutramine—obesity	2.16e-05	0.000209	CcSEcCtD
Citalopram—Skin disorder—Sibutramine—obesity	2.15e-05	0.000208	CcSEcCtD
Citalopram—Eosinophilia—Topiramate—obesity	2.14e-05	0.000207	CcSEcCtD
Citalopram—Hyperhidrosis—Sibutramine—obesity	2.14e-05	0.000207	CcSEcCtD
Citalopram—Malaise—Bupropion—obesity	2.13e-05	0.000207	CcSEcCtD
Citalopram—Vertigo—Bupropion—obesity	2.13e-05	0.000206	CcSEcCtD
Citalopram—Syncope—Bupropion—obesity	2.12e-05	0.000206	CcSEcCtD
Citalopram—Pancreatitis—Topiramate—obesity	2.12e-05	0.000205	CcSEcCtD
Citalopram—Leukopenia—Bupropion—obesity	2.12e-05	0.000205	CcSEcCtD
Citalopram—Anorexia—Sibutramine—obesity	2.11e-05	0.000205	CcSEcCtD
Citalopram—Angina pectoris—Topiramate—obesity	2.11e-05	0.000204	CcSEcCtD
Citalopram—Sweating increased—Topiramate—obesity	2.11e-05	0.000204	CcSEcCtD
Citalopram—Palpitations—Bupropion—obesity	2.09e-05	0.000203	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Orlistat—obesity	2.09e-05	0.000202	CcSEcCtD
Citalopram—Bronchitis—Topiramate—obesity	2.08e-05	0.000202	CcSEcCtD
Citalopram—Loss of consciousness—Bupropion—obesity	2.08e-05	0.000201	CcSEcCtD
Citalopram—Abdominal discomfort—Topiramate—obesity	2.07e-05	0.000201	CcSEcCtD
Citalopram—Insomnia—Orlistat—obesity	2.07e-05	0.000201	CcSEcCtD
Citalopram—Hypotension—Sibutramine—obesity	2.07e-05	0.0002	CcSEcCtD
Citalopram—Cough—Bupropion—obesity	2.07e-05	0.0002	CcSEcCtD
Citalopram—Paraesthesia—Orlistat—obesity	2.06e-05	0.000199	CcSEcCtD
Citalopram—Pancytopenia—Topiramate—obesity	2.05e-05	0.000199	CcSEcCtD
Citalopram—Convulsion—Bupropion—obesity	2.05e-05	0.000199	CcSEcCtD
Citalopram—Hypertension—Bupropion—obesity	2.04e-05	0.000198	CcSEcCtD
Citalopram—Dysuria—Topiramate—obesity	2.02e-05	0.000196	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Sibutramine—obesity	2.02e-05	0.000195	CcSEcCtD
Citalopram—Dyspepsia—Orlistat—obesity	2.02e-05	0.000195	CcSEcCtD
Citalopram—Chest pain—Bupropion—obesity	2.01e-05	0.000195	CcSEcCtD
Citalopram—Arthralgia—Bupropion—obesity	2.01e-05	0.000195	CcSEcCtD
Citalopram—Myalgia—Bupropion—obesity	2.01e-05	0.000195	CcSEcCtD
Citalopram—Upper respiratory tract infection—Topiramate—obesity	2.01e-05	0.000195	CcSEcCtD
Citalopram—Anxiety—Bupropion—obesity	2.01e-05	0.000194	CcSEcCtD
Citalopram—Insomnia—Sibutramine—obesity	2e-05	0.000194	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	2e-05	0.000194	CcSEcCtD
Citalopram—Pollakiuria—Topiramate—obesity	2e-05	0.000194	CcSEcCtD
Citalopram—Erectile dysfunction—Topiramate—obesity	1.99e-05	0.000193	CcSEcCtD
Citalopram—Discomfort—Bupropion—obesity	1.99e-05	0.000193	CcSEcCtD
Citalopram—Decreased appetite—Orlistat—obesity	1.99e-05	0.000193	CcSEcCtD
Citalopram—Paraesthesia—Sibutramine—obesity	1.99e-05	0.000193	CcSEcCtD
Citalopram—Gastrointestinal disorder—Orlistat—obesity	1.98e-05	0.000191	CcSEcCtD
Citalopram—Dyspnoea—Sibutramine—obesity	1.98e-05	0.000191	CcSEcCtD
Citalopram—Photosensitivity reaction—Topiramate—obesity	1.98e-05	0.000191	CcSEcCtD
Citalopram—Fatigue—Orlistat—obesity	1.97e-05	0.000191	CcSEcCtD
Citalopram—Dry mouth—Bupropion—obesity	1.97e-05	0.000191	CcSEcCtD
Citalopram—Somnolence—Sibutramine—obesity	1.97e-05	0.000191	CcSEcCtD
Citalopram—Weight increased—Topiramate—obesity	1.97e-05	0.000191	CcSEcCtD
Citalopram—Weight decreased—Topiramate—obesity	1.96e-05	0.00019	CcSEcCtD
Citalopram—Pain—Orlistat—obesity	1.96e-05	0.00019	CcSEcCtD
Citalopram—Hyperglycaemia—Topiramate—obesity	1.95e-05	0.000189	CcSEcCtD
Citalopram—Dyspepsia—Sibutramine—obesity	1.95e-05	0.000189	CcSEcCtD
Citalopram—Confusional state—Bupropion—obesity	1.95e-05	0.000189	CcSEcCtD
Citalopram—Pneumonia—Topiramate—obesity	1.94e-05	0.000188	CcSEcCtD
Citalopram—Oedema—Bupropion—obesity	1.93e-05	0.000187	CcSEcCtD
Citalopram—Anaphylactic shock—Bupropion—obesity	1.93e-05	0.000187	CcSEcCtD
Citalopram—Infestation—Topiramate—obesity	1.93e-05	0.000187	CcSEcCtD
Citalopram—Infestation NOS—Topiramate—obesity	1.93e-05	0.000187	CcSEcCtD
Citalopram—Decreased appetite—Sibutramine—obesity	1.93e-05	0.000187	CcSEcCtD
Citalopram—Depression—Topiramate—obesity	1.92e-05	0.000186	CcSEcCtD
Citalopram—Infection—Bupropion—obesity	1.92e-05	0.000186	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Topiramate—obesity	1.91e-05	0.000185	CcSEcCtD
Citalopram—Gastrointestinal disorder—Sibutramine—obesity	1.91e-05	0.000185	CcSEcCtD
Citalopram—Shock—Bupropion—obesity	1.9e-05	0.000184	CcSEcCtD
Citalopram—Pain—Sibutramine—obesity	1.89e-05	0.000183	CcSEcCtD
Citalopram—Constipation—Sibutramine—obesity	1.89e-05	0.000183	CcSEcCtD
Citalopram—Nervous system disorder—Bupropion—obesity	1.89e-05	0.000183	CcSEcCtD
Citalopram—Neuropathy peripheral—Topiramate—obesity	1.89e-05	0.000183	CcSEcCtD
Citalopram—Thrombocytopenia—Bupropion—obesity	1.89e-05	0.000183	CcSEcCtD
Citalopram—Feeling abnormal—Orlistat—obesity	1.89e-05	0.000183	CcSEcCtD
Citalopram—Tachycardia—Bupropion—obesity	1.88e-05	0.000183	CcSEcCtD
Citalopram—Stomatitis—Topiramate—obesity	1.88e-05	0.000182	CcSEcCtD
Citalopram—Skin disorder—Bupropion—obesity	1.88e-05	0.000182	CcSEcCtD
Citalopram—Conjunctivitis—Topiramate—obesity	1.88e-05	0.000182	CcSEcCtD
Citalopram—Urinary tract infection—Topiramate—obesity	1.88e-05	0.000182	CcSEcCtD
Citalopram—Gastrointestinal pain—Orlistat—obesity	1.87e-05	0.000181	CcSEcCtD
Citalopram—Hyperhidrosis—Bupropion—obesity	1.87e-05	0.000181	CcSEcCtD
Citalopram—Anorexia—Bupropion—obesity	1.84e-05	0.000178	CcSEcCtD
Citalopram—Haematuria—Topiramate—obesity	1.84e-05	0.000178	CcSEcCtD
Citalopram—Feeling abnormal—Sibutramine—obesity	1.83e-05	0.000177	CcSEcCtD
Citalopram—Epistaxis—Topiramate—obesity	1.82e-05	0.000176	CcSEcCtD
Citalopram—Urticaria—Orlistat—obesity	1.82e-05	0.000176	CcSEcCtD
Citalopram—Gastrointestinal pain—Sibutramine—obesity	1.81e-05	0.000175	CcSEcCtD
Citalopram—Sinusitis—Topiramate—obesity	1.81e-05	0.000175	CcSEcCtD
Citalopram—Abdominal pain—Orlistat—obesity	1.81e-05	0.000175	CcSEcCtD
Citalopram—Body temperature increased—Orlistat—obesity	1.81e-05	0.000175	CcSEcCtD
Citalopram—Hypotension—Bupropion—obesity	1.8e-05	0.000175	CcSEcCtD
Citalopram—Agranulocytosis—Topiramate—obesity	1.8e-05	0.000174	CcSEcCtD
Citalopram—Bradycardia—Topiramate—obesity	1.76e-05	0.000171	CcSEcCtD
Citalopram—Urticaria—Sibutramine—obesity	1.76e-05	0.00017	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Bupropion—obesity	1.76e-05	0.00017	CcSEcCtD
Citalopram—Abdominal pain—Sibutramine—obesity	1.75e-05	0.00017	CcSEcCtD
Citalopram—Body temperature increased—Sibutramine—obesity	1.75e-05	0.00017	CcSEcCtD
Citalopram—Insomnia—Bupropion—obesity	1.75e-05	0.000169	CcSEcCtD
Citalopram—Haemoglobin—Topiramate—obesity	1.74e-05	0.000169	CcSEcCtD
Citalopram—Rhinitis—Topiramate—obesity	1.74e-05	0.000168	CcSEcCtD
Citalopram—Paraesthesia—Bupropion—obesity	1.73e-05	0.000168	CcSEcCtD
Citalopram—Haemorrhage—Topiramate—obesity	1.73e-05	0.000168	CcSEcCtD
Citalopram—Hepatitis—Topiramate—obesity	1.73e-05	0.000168	CcSEcCtD
Citalopram—Hypoaesthesia—Topiramate—obesity	1.72e-05	0.000167	CcSEcCtD
Citalopram—Hallucination—Topiramate—obesity	1.72e-05	0.000167	CcSEcCtD
Citalopram—Dyspnoea—Bupropion—obesity	1.72e-05	0.000167	CcSEcCtD
Citalopram—Pharyngitis—Topiramate—obesity	1.72e-05	0.000166	CcSEcCtD
Citalopram—Somnolence—Bupropion—obesity	1.72e-05	0.000166	CcSEcCtD
Citalopram—Urinary tract disorder—Topiramate—obesity	1.71e-05	0.000166	CcSEcCtD
Citalopram—Oedema peripheral—Topiramate—obesity	1.71e-05	0.000165	CcSEcCtD
Citalopram—Connective tissue disorder—Topiramate—obesity	1.7e-05	0.000165	CcSEcCtD
Citalopram—Dyspepsia—Bupropion—obesity	1.7e-05	0.000165	CcSEcCtD
Citalopram—Urethral disorder—Topiramate—obesity	1.7e-05	0.000164	CcSEcCtD
Citalopram—Hypersensitivity—Orlistat—obesity	1.69e-05	0.000163	CcSEcCtD
Citalopram—Decreased appetite—Bupropion—obesity	1.68e-05	0.000163	CcSEcCtD
Citalopram—Visual impairment—Topiramate—obesity	1.67e-05	0.000162	CcSEcCtD
Citalopram—Gastrointestinal disorder—Bupropion—obesity	1.67e-05	0.000161	CcSEcCtD
Citalopram—Fatigue—Bupropion—obesity	1.67e-05	0.000161	CcSEcCtD
Citalopram—Pain—Bupropion—obesity	1.65e-05	0.00016	CcSEcCtD
Citalopram—Constipation—Bupropion—obesity	1.65e-05	0.00016	CcSEcCtD
Citalopram—Asthenia—Orlistat—obesity	1.64e-05	0.000159	CcSEcCtD
Citalopram—Erythema multiforme—Topiramate—obesity	1.64e-05	0.000159	CcSEcCtD
Citalopram—Hypersensitivity—Sibutramine—obesity	1.63e-05	0.000158	CcSEcCtD
Citalopram—Pruritus—Orlistat—obesity	1.62e-05	0.000157	CcSEcCtD
Citalopram—Eye disorder—Topiramate—obesity	1.62e-05	0.000157	CcSEcCtD
Citalopram—Tinnitus—Topiramate—obesity	1.61e-05	0.000156	CcSEcCtD
Citalopram—Flushing—Topiramate—obesity	1.61e-05	0.000156	CcSEcCtD
Citalopram—Cardiac disorder—Topiramate—obesity	1.61e-05	0.000156	CcSEcCtD
Citalopram—Feeling abnormal—Bupropion—obesity	1.59e-05	0.000154	CcSEcCtD
Citalopram—Asthenia—Sibutramine—obesity	1.59e-05	0.000154	CcSEcCtD
Citalopram—Gastrointestinal pain—Bupropion—obesity	1.58e-05	0.000153	CcSEcCtD
Citalopram—Angiopathy—Topiramate—obesity	1.57e-05	0.000152	CcSEcCtD
Citalopram—Pruritus—Sibutramine—obesity	1.57e-05	0.000152	CcSEcCtD
Citalopram—Diarrhoea—Orlistat—obesity	1.57e-05	0.000152	CcSEcCtD
Citalopram—Immune system disorder—Topiramate—obesity	1.56e-05	0.000152	CcSEcCtD
Citalopram—Mediastinal disorder—Topiramate—obesity	1.56e-05	0.000151	CcSEcCtD
Citalopram—Chills—Topiramate—obesity	1.55e-05	0.000151	CcSEcCtD
Citalopram—Urticaria—Bupropion—obesity	1.53e-05	0.000149	CcSEcCtD
Citalopram—Alopecia—Topiramate—obesity	1.53e-05	0.000148	CcSEcCtD
Citalopram—Abdominal pain—Bupropion—obesity	1.53e-05	0.000148	CcSEcCtD
Citalopram—Body temperature increased—Bupropion—obesity	1.53e-05	0.000148	CcSEcCtD
Citalopram—Mental disorder—Topiramate—obesity	1.52e-05	0.000147	CcSEcCtD
Citalopram—Diarrhoea—Sibutramine—obesity	1.52e-05	0.000147	CcSEcCtD
Citalopram—Dizziness—Orlistat—obesity	1.51e-05	0.000147	CcSEcCtD
Citalopram—Erythema—Topiramate—obesity	1.51e-05	0.000146	CcSEcCtD
Citalopram—Malnutrition—Topiramate—obesity	1.51e-05	0.000146	CcSEcCtD
Citalopram—Flatulence—Topiramate—obesity	1.49e-05	0.000144	CcSEcCtD
Citalopram—Tension—Topiramate—obesity	1.48e-05	0.000143	CcSEcCtD
Citalopram—Dysgeusia—Topiramate—obesity	1.48e-05	0.000143	CcSEcCtD
Citalopram—Dizziness—Sibutramine—obesity	1.46e-05	0.000142	CcSEcCtD
Citalopram—Nervousness—Topiramate—obesity	1.46e-05	0.000142	CcSEcCtD
Citalopram—Back pain—Topiramate—obesity	1.46e-05	0.000141	CcSEcCtD
Citalopram—Vomiting—Orlistat—obesity	1.46e-05	0.000141	CcSEcCtD
Citalopram—Muscle spasms—Topiramate—obesity	1.45e-05	0.00014	CcSEcCtD
Citalopram—Rash—Orlistat—obesity	1.44e-05	0.00014	CcSEcCtD
Citalopram—Dermatitis—Orlistat—obesity	1.44e-05	0.00014	CcSEcCtD
Citalopram—Headache—Orlistat—obesity	1.43e-05	0.000139	CcSEcCtD
Citalopram—Hypersensitivity—Bupropion—obesity	1.42e-05	0.000138	CcSEcCtD
Citalopram—Vision blurred—Topiramate—obesity	1.42e-05	0.000138	CcSEcCtD
Citalopram—Tremor—Topiramate—obesity	1.41e-05	0.000137	CcSEcCtD
Citalopram—Vomiting—Sibutramine—obesity	1.41e-05	0.000136	CcSEcCtD
Citalopram—Ill-defined disorder—Topiramate—obesity	1.4e-05	0.000135	CcSEcCtD
Citalopram—Rash—Sibutramine—obesity	1.4e-05	0.000135	CcSEcCtD
Citalopram—Dermatitis—Sibutramine—obesity	1.4e-05	0.000135	CcSEcCtD
Citalopram—Anaemia—Topiramate—obesity	1.39e-05	0.000135	CcSEcCtD
Citalopram—Headache—Sibutramine—obesity	1.39e-05	0.000134	CcSEcCtD
Citalopram—Asthenia—Bupropion—obesity	1.39e-05	0.000134	CcSEcCtD
Citalopram—Agitation—Topiramate—obesity	1.39e-05	0.000134	CcSEcCtD
Citalopram—Pruritus—Bupropion—obesity	1.37e-05	0.000132	CcSEcCtD
Citalopram—Nausea—Orlistat—obesity	1.36e-05	0.000132	CcSEcCtD
Citalopram—Malaise—Topiramate—obesity	1.36e-05	0.000132	CcSEcCtD
Citalopram—Vertigo—Topiramate—obesity	1.35e-05	0.000131	CcSEcCtD
Citalopram—Syncope—Topiramate—obesity	1.35e-05	0.000131	CcSEcCtD
Citalopram—Leukopenia—Topiramate—obesity	1.35e-05	0.000131	CcSEcCtD
Citalopram—Palpitations—Topiramate—obesity	1.33e-05	0.000129	CcSEcCtD
Citalopram—Loss of consciousness—Topiramate—obesity	1.33e-05	0.000128	CcSEcCtD
Citalopram—Diarrhoea—Bupropion—obesity	1.32e-05	0.000128	CcSEcCtD
Citalopram—Nausea—Sibutramine—obesity	1.32e-05	0.000127	CcSEcCtD
Citalopram—Cough—Topiramate—obesity	1.32e-05	0.000127	CcSEcCtD
Citalopram—Convulsion—Topiramate—obesity	1.31e-05	0.000127	CcSEcCtD
Citalopram—Hypertension—Topiramate—obesity	1.3e-05	0.000126	CcSEcCtD
Citalopram—Myalgia—Topiramate—obesity	1.28e-05	0.000124	CcSEcCtD
Citalopram—Arthralgia—Topiramate—obesity	1.28e-05	0.000124	CcSEcCtD
Citalopram—Chest pain—Topiramate—obesity	1.28e-05	0.000124	CcSEcCtD
Citalopram—Anxiety—Topiramate—obesity	1.28e-05	0.000124	CcSEcCtD
Citalopram—Dizziness—Bupropion—obesity	1.28e-05	0.000124	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	1.27e-05	0.000123	CcSEcCtD
Citalopram—Discomfort—Topiramate—obesity	1.27e-05	0.000123	CcSEcCtD
Citalopram—Dry mouth—Topiramate—obesity	1.26e-05	0.000122	CcSEcCtD
Citalopram—Confusional state—Topiramate—obesity	1.24e-05	0.00012	CcSEcCtD
Citalopram—Oedema—Topiramate—obesity	1.23e-05	0.000119	CcSEcCtD
Citalopram—Vomiting—Bupropion—obesity	1.23e-05	0.000119	CcSEcCtD
Citalopram—Infection—Topiramate—obesity	1.22e-05	0.000118	CcSEcCtD
Citalopram—Rash—Bupropion—obesity	1.22e-05	0.000118	CcSEcCtD
Citalopram—Dermatitis—Bupropion—obesity	1.22e-05	0.000118	CcSEcCtD
Citalopram—Shock—Topiramate—obesity	1.21e-05	0.000117	CcSEcCtD
Citalopram—Headache—Bupropion—obesity	1.21e-05	0.000117	CcSEcCtD
Citalopram—Nervous system disorder—Topiramate—obesity	1.21e-05	0.000117	CcSEcCtD
Citalopram—Thrombocytopenia—Topiramate—obesity	1.2e-05	0.000117	CcSEcCtD
Citalopram—Tachycardia—Topiramate—obesity	1.2e-05	0.000116	CcSEcCtD
Citalopram—Skin disorder—Topiramate—obesity	1.2e-05	0.000116	CcSEcCtD
Citalopram—Hyperhidrosis—Topiramate—obesity	1.19e-05	0.000115	CcSEcCtD
Citalopram—Anorexia—Topiramate—obesity	1.17e-05	0.000114	CcSEcCtD
Citalopram—Hypotension—Topiramate—obesity	1.15e-05	0.000111	CcSEcCtD
Citalopram—Nausea—Bupropion—obesity	1.15e-05	0.000111	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Topiramate—obesity	1.12e-05	0.000109	CcSEcCtD
Citalopram—Insomnia—Topiramate—obesity	1.11e-05	0.000108	CcSEcCtD
Citalopram—Paraesthesia—Topiramate—obesity	1.1e-05	0.000107	CcSEcCtD
Citalopram—Dyspnoea—Topiramate—obesity	1.1e-05	0.000106	CcSEcCtD
Citalopram—Somnolence—Topiramate—obesity	1.09e-05	0.000106	CcSEcCtD
Citalopram—Dyspepsia—Topiramate—obesity	1.08e-05	0.000105	CcSEcCtD
Citalopram—Decreased appetite—Topiramate—obesity	1.07e-05	0.000104	CcSEcCtD
Citalopram—Gastrointestinal disorder—Topiramate—obesity	1.06e-05	0.000103	CcSEcCtD
Citalopram—Fatigue—Topiramate—obesity	1.06e-05	0.000103	CcSEcCtD
Citalopram—Pain—Topiramate—obesity	1.05e-05	0.000102	CcSEcCtD
Citalopram—Constipation—Topiramate—obesity	1.05e-05	0.000102	CcSEcCtD
Citalopram—Feeling abnormal—Topiramate—obesity	1.01e-05	9.82e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Topiramate—obesity	1.01e-05	9.74e-05	CcSEcCtD
Citalopram—Urticaria—Topiramate—obesity	9.78e-06	9.47e-05	CcSEcCtD
Citalopram—Abdominal pain—Topiramate—obesity	9.73e-06	9.42e-05	CcSEcCtD
Citalopram—Body temperature increased—Topiramate—obesity	9.73e-06	9.42e-05	CcSEcCtD
Citalopram—Hypersensitivity—Topiramate—obesity	9.07e-06	8.78e-05	CcSEcCtD
Citalopram—Asthenia—Topiramate—obesity	8.83e-06	8.55e-05	CcSEcCtD
Citalopram—Pruritus—Topiramate—obesity	8.71e-06	8.43e-05	CcSEcCtD
Citalopram—Diarrhoea—Topiramate—obesity	8.42e-06	8.15e-05	CcSEcCtD
Citalopram—Dizziness—Topiramate—obesity	8.14e-06	7.88e-05	CcSEcCtD
Citalopram—Vomiting—Topiramate—obesity	7.82e-06	7.58e-05	CcSEcCtD
Citalopram—Rash—Topiramate—obesity	7.76e-06	7.51e-05	CcSEcCtD
Citalopram—Dermatitis—Topiramate—obesity	7.75e-06	7.51e-05	CcSEcCtD
Citalopram—Headache—Topiramate—obesity	7.71e-06	7.47e-05	CcSEcCtD
Citalopram—Nausea—Topiramate—obesity	7.31e-06	7.08e-05	CcSEcCtD
Citalopram—ADRA1A—Signaling Pathways—IRS1—obesity	1.13e-06	2.41e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RHOA—obesity	1.13e-06	2.41e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—INS—obesity	1.13e-06	2.41e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NCOA1—obesity	1.13e-06	2.4e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PPARG—obesity	1.12e-06	2.4e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SDC1—obesity	1.12e-06	2.39e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NOS3—obesity	1.11e-06	2.38e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PIK3R1—obesity	1.11e-06	2.38e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP19A1—obesity	1.11e-06	2.37e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—STK11—obesity	1.11e-06	2.37e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—POMC—obesity	1.11e-06	2.37e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—POMC—obesity	1.11e-06	2.37e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—POMC—obesity	1.1e-06	2.36e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—INS—obesity	1.1e-06	2.36e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CD36—obesity	1.1e-06	2.35e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—INS—obesity	1.1e-06	2.35e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AKR1C3—obesity	1.1e-06	2.35e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—INS—obesity	1.1e-06	2.35e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—LPL—obesity	1.09e-06	2.33e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—POMC—obesity	1.09e-06	2.32e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL2—obesity	1.08e-06	2.32e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SCARB1—obesity	1.08e-06	2.31e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—INS—obesity	1.08e-06	2.31e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL2—obesity	1.08e-06	2.31e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MTHFR—obesity	1.07e-06	2.29e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GPX1—obesity	1.07e-06	2.28e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1—obesity	1.07e-06	2.28e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AKT2—obesity	1.06e-06	2.27e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL2—obesity	1.06e-06	2.27e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1—obesity	1.06e-06	2.27e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PIK3CA—obesity	1.06e-06	2.27e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AKT2—obesity	1.06e-06	2.27e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SREBF1—obesity	1.05e-06	2.24e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPARA—obesity	1.05e-06	2.24e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PIK3CD—obesity	1.05e-06	2.23e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1—obesity	1.05e-06	2.23e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AKT2—obesity	1.04e-06	2.23e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MTHFR—obesity	1.04e-06	2.23e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CD36—obesity	1.04e-06	2.22e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALB—obesity	1.03e-06	2.21e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—COMT—obesity	1.03e-06	2.2e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PIK3CB—obesity	1.03e-06	2.2e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MTOR—obesity	1.03e-06	2.2e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPARA—obesity	1.02e-06	2.19e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PIK3CD—obesity	1.02e-06	2.19e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PIK3CD—obesity	1.02e-06	2.19e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GOT2—obesity	1.02e-06	2.18e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PIK3CD—obesity	1.02e-06	2.18e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARGC1A—obesity	1.02e-06	2.17e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GNB3—obesity	1.02e-06	2.17e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AGT—obesity	1.02e-06	2.17e-05	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—PIK3CA—obesity	1.01e-06	2.16e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HMOX1—obesity	1.01e-06	2.16e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SERPINE1—obesity	1.01e-06	2.16e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALB—obesity	1.01e-06	2.16e-05	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—PIK3CA—obesity	1.01e-06	2.16e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SERPINE1—obesity	1.01e-06	2.15e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PIK3CD—obesity	1e-06	2.14e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—FASN—obesity	1e-06	2.14e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOE—obesity	9.96e-07	2.13e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—BCHE—obesity	9.96e-07	2.13e-05	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	9.94e-07	2.12e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SERPINE1—obesity	9.93e-07	2.12e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AGT—obesity	9.92e-07	2.12e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GNAS—obesity	9.9e-07	2.12e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—NOS3—obesity	9.88e-07	2.11e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PIK3R1—obesity	9.88e-07	2.11e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CAV1—obesity	9.87e-07	2.11e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOA1—obesity	9.85e-07	2.1e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TYK2—obesity	9.84e-07	2.1e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MTHFR—obesity	9.84e-07	2.1e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TYK2—obesity	9.81e-07	2.1e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RHOA—obesity	9.76e-07	2.08e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RHOA—obesity	9.73e-07	2.08e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOE—obesity	9.72e-07	2.08e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOB—obesity	9.7e-07	2.07e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PIK3R1—obesity	9.67e-07	2.07e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—NOS3—obesity	9.67e-07	2.07e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NOS3—obesity	9.66e-07	2.06e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PIK3R1—obesity	9.66e-07	2.06e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TYK2—obesity	9.66e-07	2.06e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARA—obesity	9.65e-07	2.06e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CAV1—obesity	9.63e-07	2.06e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PIK3R1—obesity	9.63e-07	2.06e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NOS3—obesity	9.63e-07	2.06e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOA1—obesity	9.61e-07	2.05e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2E1—obesity	9.61e-07	2.05e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RHOA—obesity	9.58e-07	2.05e-05	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AKT1—obesity	9.55e-07	2.04e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NQO1—obesity	9.5e-07	2.03e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PIK3R1—obesity	9.48e-07	2.02e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NOS3—obesity	9.48e-07	2.02e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.43e-07	2.01e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—obesity	9.4e-07	2.01e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AGT—obesity	9.35e-07	2e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—LPL—obesity	9.26e-07	1.98e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PIK3CA—obesity	9.2e-07	1.97e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PIK3CA—obesity	9.17e-07	1.96e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOE—obesity	9.16e-07	1.96e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PIK3CB—obesity	9.12e-07	1.95e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GCG—obesity	9.11e-07	1.95e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SLC2A4—obesity	9.11e-07	1.95e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CAV1—obesity	9.08e-07	1.94e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOA1—obesity	9.06e-07	1.93e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GPX1—obesity	9.03e-07	1.93e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—obesity	9.03e-07	1.93e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PIK3CA—obesity	9.03e-07	1.93e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3CG—obesity	8.99e-07	1.92e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYCS—obesity	8.99e-07	1.92e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MMP9—obesity	8.94e-07	1.91e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PIK3CB—obesity	8.93e-07	1.91e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MTOR—obesity	8.92e-07	1.9e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PIK3CB—obesity	8.92e-07	1.9e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MTOR—obesity	8.89e-07	1.9e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PIK3CB—obesity	8.89e-07	1.9e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—obesity	8.85e-07	1.89e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GGT1—obesity	8.82e-07	1.88e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GOT1—obesity	8.82e-07	1.88e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CD36—obesity	8.8e-07	1.88e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3CG—obesity	8.77e-07	1.87e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PIK3CB—obesity	8.75e-07	1.87e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MTOR—obesity	8.75e-07	1.87e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MAPK8—obesity	8.7e-07	1.86e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NCOA1—obesity	8.69e-07	1.86e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPARG—obesity	8.68e-07	1.85e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AKT1—obesity	8.67e-07	1.85e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—STK11—obesity	8.56e-07	1.83e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP19A1—obesity	8.56e-07	1.83e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—POMC—obesity	8.56e-07	1.83e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—INS—obesity	8.51e-07	1.82e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPARG—obesity	8.47e-07	1.81e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—POMC—obesity	8.35e-07	1.78e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MTHFR—obesity	8.34e-07	1.78e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—INS—obesity	8.31e-07	1.77e-05	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AKT1—obesity	8.28e-07	1.77e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3CG—obesity	8.27e-07	1.77e-05	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AKT1—obesity	8.25e-07	1.76e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARA—obesity	8.18e-07	1.75e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—obesity	8.15e-07	1.74e-05	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AKT1—obesity	8.12e-07	1.74e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—obesity	8.12e-07	1.73e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—obesity	8e-07	1.71e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARG—obesity	7.98e-07	1.7e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—COMT—obesity	7.96e-07	1.7e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—STAT3—obesity	7.95e-07	1.7e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AGT—obesity	7.92e-07	1.69e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3CD—obesity	7.9e-07	1.69e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—POMC—obesity	7.87e-07	1.68e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARGC1A—obesity	7.85e-07	1.68e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GNB3—obesity	7.85e-07	1.68e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—INS—obesity	7.83e-07	1.67e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HMOX1—obesity	7.81e-07	1.67e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALB—obesity	7.8e-07	1.67e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOE—obesity	7.76e-07	1.66e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MMP9—obesity	7.75e-07	1.66e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MMP9—obesity	7.73e-07	1.65e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3CD—obesity	7.71e-07	1.65e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CAV1—obesity	7.69e-07	1.64e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOA1—obesity	7.67e-07	1.64e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GNAS—obesity	7.64e-07	1.63e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALB—obesity	7.61e-07	1.63e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MMP9—obesity	7.61e-07	1.62e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MAPK8—obesity	7.54e-07	1.61e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AKT1—obesity	7.52e-07	1.61e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MAPK8—obesity	7.51e-07	1.6e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AKT1—obesity	7.49e-07	1.6e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOB—obesity	7.48e-07	1.6e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3R1—obesity	7.46e-07	1.59e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—NOS3—obesity	7.46e-07	1.59e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MAPK8—obesity	7.4e-07	1.58e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MYC—obesity	7.39e-07	1.58e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AKT1—obesity	7.38e-07	1.58e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TGFB1—obesity	7.37e-07	1.57e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.35e-07	1.57e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3R1—obesity	7.28e-07	1.56e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—NOS3—obesity	7.28e-07	1.56e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3CD—obesity	7.27e-07	1.55e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALB—obesity	7.18e-07	1.53e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—LPL—obesity	7.15e-07	1.53e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3CG—obesity	7e-07	1.5e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPX1—obesity	6.97e-07	1.49e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—STAT3—obesity	6.89e-07	1.47e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3CB—obesity	6.89e-07	1.47e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—STAT3—obesity	6.87e-07	1.47e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—NOS3—obesity	6.86e-07	1.47e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3R1—obesity	6.86e-07	1.47e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—obesity	6.83e-07	1.46e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CD36—obesity	6.79e-07	1.45e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—STAT3—obesity	6.76e-07	1.44e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARG—obesity	6.76e-07	1.44e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3CB—obesity	6.72e-07	1.44e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—POMC—obesity	6.67e-07	1.42e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—obesity	6.66e-07	1.42e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—INS—obesity	6.63e-07	1.42e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MTHFR—obesity	6.43e-07	1.37e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MYC—obesity	6.4e-07	1.37e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TGFB1—obesity	6.39e-07	1.36e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MYC—obesity	6.38e-07	1.36e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TGFB1—obesity	6.37e-07	1.36e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3CB—obesity	6.34e-07	1.35e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARA—obesity	6.31e-07	1.35e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MYC—obesity	6.28e-07	1.34e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—obesity	6.28e-07	1.34e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PIK3CA—obesity	6.27e-07	1.34e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TGFB1—obesity	6.27e-07	1.34e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3CD—obesity	6.16e-07	1.32e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AGT—obesity	6.11e-07	1.31e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALB—obesity	6.08e-07	1.3e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOE—obesity	5.99e-07	1.28e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CAV1—obesity	5.93e-07	1.27e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOA1—obesity	5.92e-07	1.26e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3R1—obesity	5.81e-07	1.24e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NOS3—obesity	5.81e-07	1.24e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PIK3CA—obesity	5.56e-07	1.19e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—obesity	5.55e-07	1.19e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PIK3CA—obesity	5.44e-07	1.16e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PIK3CA—obesity	5.44e-07	1.16e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PIK3CA—obesity	5.42e-07	1.16e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3CG—obesity	5.41e-07	1.15e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3CB—obesity	5.37e-07	1.15e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PIK3CA—obesity	5.33e-07	1.14e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—obesity	5.32e-07	1.14e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARG—obesity	5.22e-07	1.11e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—POMC—obesity	5.15e-07	1.1e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AKT1—obesity	5.12e-07	1.09e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—INS—obesity	5.12e-07	1.09e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—obesity	4.81e-07	1.03e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—obesity	4.8e-07	1.02e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3CD—obesity	4.75e-07	1.02e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—obesity	4.72e-07	1.01e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALB—obesity	4.69e-07	1e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—AKT1—obesity	4.54e-07	9.7e-06	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3R1—obesity	4.49e-07	9.59e-06	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NOS3—obesity	4.49e-07	9.59e-06	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—AKT1—obesity	4.45e-07	9.5e-06	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AKT1—obesity	4.44e-07	9.48e-06	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AKT1—obesity	4.43e-07	9.45e-06	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AKT1—obesity	4.36e-07	9.31e-06	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3CA—obesity	4.2e-07	8.97e-06	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3CB—obesity	4.14e-07	8.85e-06	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—obesity	4.1e-07	8.77e-06	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3CA—obesity	4.1e-07	8.75e-06	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3CA—obesity	3.86e-07	8.25e-06	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AKT1—obesity	3.43e-07	7.33e-06	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AKT1—obesity	3.35e-07	7.15e-06	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3CA—obesity	3.27e-07	6.99e-06	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AKT1—obesity	3.16e-07	6.74e-06	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AKT1—obesity	2.67e-07	5.71e-06	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3CA—obesity	2.53e-07	5.39e-06	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AKT1—obesity	2.06e-07	4.41e-06	CbGpPWpGaD
